ResMed (RMD) Tops Q1 EPS by 15c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q1 EPS of $2.20, $0.15 better than the analyst estimate of $2.05. Revenue for the quarter came in at $1.22 billion versus the consensus estimate of $1.19 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
